Literature DB >> 17048191

Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai.

Siriporn Chanchay1, Rungsunn Tungtrongchitr, Talabporn Harnroongroj, Benjaluck Phonrat, Orapin Rungseesakorn, Suporn Paksanont, Somchai Pooudong, Sastri Saowakontha, Chusak Varongchayakul.   

Abstract

This study investigated levels of fasting plasma glucose (FBS), homeostasis model of the assessment of the insulin resistance (HOMA), lipid profile, insulin, and resistin hormones in 202 individuals, divided into four groups. Two groups had type II diabetes mellitus (DM): one group had been overnourished (DM/OB) (body mass index: BMI equal or above 25) and the other had not (DM/nOB). Two additional groups not suffering from diabetes were either overnourished (nDM/OB) or of normal nutritional status (nDM/nOB). Only the DM/OB group had insulin levels elevated above the other three groups. Resistin levels had been lowest in the nDM/nOB group. When participants of the two nOB groups were pooled into one group and the subjects of the two OB groups were combined into another group, the median plasma resistin levels of the OB groups were significantly higher compared with the nOB groups. Likewise the DM groups had higher resistin levels than the nDM groups. A significant correlation of plasma resistin with BMI, waist circumference, waist-to-hip ratio, FBS, and HOMA score had been observed. The result suggests that plasma resistin has a role in linking central obesity and obesity-related insulin resistance to type II diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048191     DOI: 10.1024/0300-9831.76.3.125

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  6 in total

1.  Association of +62 G>A Polymorphism in the Resistin Gene with Type 2 Diabetes Mellitus among Thais: Case-Control Study.

Authors:  Theerawut Thammakun; Wongsa Laohasiriwong; Ratthaphol Kraiklang; Nittaya Saengprajak
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.

Authors:  Dominique Hansen; Paul Dendale; Milou Beelen; Richard A M Jonkers; Annelies Mullens; Luk Corluy; Romain Meeusen; Luc J C van Loon
Journal:  Eur J Appl Physiol       Date:  2010-02-04       Impact factor: 3.078

3.  Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.

Authors:  Christin Heidemann; Qi Sun; Rob M van Dam; James B Meigs; Cuilin Zhang; Shelley S Tworoger; Christos S Mantzoros; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

4.  Advanced oxidation protein products in obese women: its relation to insulin resistance and resistin.

Authors:  H Koçak; Y Oner-Iyidoğan; F Gürdöl; P Oner; R Süzme; D Esin; H Işsever
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

5.  The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children.

Authors:  Tulay Guran; Serap Turan; Abdullah Bereket; Teoman Akcay; Goksenin Unluguzel; Firdevs Bas; Hulya Gunoz; Nurcin Saka; Ruveyde Bundak; Feyza Darendeliler; Pinar Isguven; Metin Yildiz; Erdal Adal; Sevil Sarikaya; Leyla Akin Baygin; Nihal Memioglu; Hasan Onal; Oya Ercan; Goncagul Haklar
Journal:  Eur J Pediatr       Date:  2008-11-29       Impact factor: 3.183

6.  Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention.

Authors:  Natasa Rajkovic; Miroslava Zamaklar; Katarina Lalic; Aleksandra Jotic; Ljiljana Lukic; Tanja Milicic; Sandra Singh; Ljubica Stosic; Nebojsa M Lalic
Journal:  Int J Environ Res Public Health       Date:  2014-04-14       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.